GB2128630B - Method of affinity purification employing monoclonal antibodies - Google Patents

Method of affinity purification employing monoclonal antibodies

Info

Publication number
GB2128630B
GB2128630B GB08332644A GB8332644A GB2128630B GB 2128630 B GB2128630 B GB 2128630B GB 08332644 A GB08332644 A GB 08332644A GB 8332644 A GB8332644 A GB 8332644A GB 2128630 B GB2128630 B GB 2128630B
Authority
GB
United Kingdom
Prior art keywords
monoclonal antibodies
affinity purification
employing monoclonal
purification employing
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08332644A
Other languages
English (en)
Other versions
GB8332644D0 (en
GB2128630A (en
Inventor
Richard M Bartholomew
Daniel E Beidler
Gary S David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of GB8332644D0 publication Critical patent/GB8332644D0/en
Publication of GB2128630A publication Critical patent/GB2128630A/en
Application granted granted Critical
Publication of GB2128630B publication Critical patent/GB2128630B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB08332644A 1982-04-12 1983-04-12 Method of affinity purification employing monoclonal antibodies Expired GB2128630B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12
PCT/US1983/000524 WO1983003678A1 (en) 1982-04-12 1983-04-12 Method of affinity purification employing monoclonal antibodies

Publications (3)

Publication Number Publication Date
GB8332644D0 GB8332644D0 (en) 1984-01-11
GB2128630A GB2128630A (en) 1984-05-02
GB2128630B true GB2128630B (en) 1986-08-28

Family

ID=23448565

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08332644A Expired GB2128630B (en) 1982-04-12 1983-04-12 Method of affinity purification employing monoclonal antibodies

Country Status (11)

Country Link
EP (1) EP0105359A4 (enrdf_load_stackoverflow)
AT (1) AT393386B (enrdf_load_stackoverflow)
AU (1) AU622099B2 (enrdf_load_stackoverflow)
CA (1) CA1209907A (enrdf_load_stackoverflow)
CH (1) CH672028A5 (enrdf_load_stackoverflow)
DK (1) DK192191D0 (enrdf_load_stackoverflow)
ES (3) ES521371A0 (enrdf_load_stackoverflow)
FI (1) FI88403C (enrdf_load_stackoverflow)
GB (1) GB2128630B (enrdf_load_stackoverflow)
IT (1) IT1219779B (enrdf_load_stackoverflow)
WO (1) WO1983003678A1 (enrdf_load_stackoverflow)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (sv) * 1987-03-06 1993-02-22 Perstorp Biolytica Adsorbent foer isokratisk affinitetskromatografi
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
DE3871799D1 (de) * 1987-07-14 1992-07-09 Univ Manchester Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
WO1998012329A2 (en) * 1996-09-20 1998-03-26 The General Hospital Corporation Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
HRP20240722T1 (hr) * 2008-04-11 2024-08-30 Chugai Seiyaku Kabushiki Kaisha Molekula koja se veže na antigene, koja se može ponavljano vezati na dvje ili više molekula antigena
TWI654203B (zh) 2010-11-30 2019-03-21 中外製藥股份有限公司 具有鈣依存性的抗原結合能力之抗體
CN112812184A (zh) 2011-02-25 2021-05-18 中外制药株式会社 FcγRIIb特异性Fc抗体
JP6322411B2 (ja) 2011-09-30 2018-05-09 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
CN113416257A (zh) 2011-11-30 2021-09-21 中外制药株式会社 包含进入细胞内以形成免疫复合体的搬运体(载体)的药物
CR20170326A (es) 2014-12-19 2017-08-22 Chugai Pharmaceutical Co Ltd Anticuerpos antimiostatina, polipéptidos que contienen regiones fc variantes, y métodos de uso
HUE056489T2 (hu) 2014-12-19 2022-02-28 Chugai Pharmaceutical Co Ltd Anti-C5 antitestek és alkalmazási eljárások
EP3394098A4 (en) 2015-12-25 2019-11-13 Chugai Seiyaku Kabushiki Kaisha ANTI-MYOSTATIN ANTIBODIES AND METHODS OF USE
CN116251182A (zh) 2016-08-05 2023-06-13 中外制药株式会社 用于预防或治疗il-8相关疾病的组合物
WO2018139623A1 (en) 2017-01-30 2018-08-02 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
CN110724204B (zh) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Fc融合蛋白的纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
EP0059598B1 (en) * 1981-02-26 1985-07-17 Unilever Plc A process and apparatus for the recovery of immunoglobulines
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
GB8332644D0 (en) 1984-01-11
ES8404858A1 (es) 1984-05-16
AU622099B2 (en) 1992-04-02
EP0105359A4 (en) 1984-08-20
ES8706964A1 (es) 1987-07-01
DK192191A (da) 1991-11-26
IT8320550A0 (it) 1983-04-12
FI834530L (fi) 1983-12-09
ES528000A0 (es) 1985-08-01
CH672028A5 (enrdf_load_stackoverflow) 1989-10-13
GB2128630A (en) 1984-05-02
ATA901983A (de) 1991-03-15
DK192191D0 (da) 1991-11-26
FI834530A0 (fi) 1983-12-09
AU7256987A (en) 1987-09-03
ES528001A0 (es) 1987-07-01
ES8506902A1 (es) 1985-08-01
AT393386B (de) 1991-10-10
FI88403C (fi) 1993-05-10
EP0105359A1 (en) 1984-04-18
IT1219779B (it) 1990-05-24
CA1209907A (en) 1986-08-19
WO1983003678A1 (en) 1983-10-27
FI88403B (fi) 1993-01-29
ES521371A0 (es) 1984-05-16

Similar Documents

Publication Publication Date Title
GB2128630B (en) Method of affinity purification employing monoclonal antibodies
GB8316001D0 (en) Monoclonal antibodies
GB8422653D0 (en) Monoclonal antibodies
GB8426463D0 (en) Monoclonal antibodies
GB8426467D0 (en) Monoclonal antibodies
GB8422650D0 (en) Monoclonal antibodies
DE3468623D1 (en) Method for purification of hbs antigen
GB2146351B (en) Monoclonal antibody
DE3266967D1 (en) Method of immunoassay
GB2163178B (en) Novel monoclonal antibody
AU1550783A (en) Method of affinity purification employing monoclonal antibodies
GB8330331D0 (en) Monoclonal antibody
GB2118300B (en) Method of immunoassay
GB8426461D0 (en) Monoclonal antibodies
GB8426464D0 (en) Monoclonal antibodies
GB8422649D0 (en) Monoclonal antibodies
GB8422651D0 (en) Monoclonal antibodies
GB8426468D0 (en) Monoclonal antibodies
GB8426470D0 (en) Monoclonal antibodies
GB8426459D0 (en) Monoclonal antibodies
GB8426465D0 (en) Monoclonal antibodies
GB8431171D0 (en) Monoclonal antibodies
IL71877A0 (en) Process for obtaining monoclonal antibodies
GB8416845D0 (en) Monoclonal antibodies
GB8426469D0 (en) Monoclonal antibodies

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930412